The Updated NHS Commercial Framework for New Medicines

March 3, 2025

Re-Launch of UK’s Innovative Licensing and Access Pathway (“ILAP”)

February 14, 2025

MHRA Consultation on Individualised mRNA Cancer Immunotherapies – Unique opportunity for a streamlined risk based regulatory framework?

February 12, 2025

The Covington European Life Sciences Symposium 2025

February 4, 2025

MHRA Consults on New UK Pre-Market Medical Device Measures

November 28, 2024

UK’s Medical Device Post-market Surveillance Statutory Instrument Laid Before Parliament – What are the Key Changes for Medical Device Regulation?

October 28, 2024

UK’s Medical Device Post-market Surveillance Statutory Instrument Laid Before Parliament – What are the Key Changes for Medical Device Regulation?

October 28, 2024